Morgan Stanley Capital International (MSCI) announced to include Pakistan in the Emerging Markets category from Frontier Markets. The formal inclusion will be done in 2017. Emerging Markets inclusion means reducing the number of listed companies from 36 to 27 in indices. Ferozsons Laboratories is featured in the 27 and is clubbed with the small market cap companies. In the last few years, Ferozsons witnessed an incredible trajectory of growth and is now amongst the top ten pharmaceutical companies in Pakistan. The status awarded to Pakistan by MSCI is a testament to the good performance of the stock exchanges in the recent years. The announcement is tipped to help bring investments into Pakistan.